Evidence map›Paper›PMID 26210446›Full record

ReviewRedox biology2015

Genetic disorders coupled to ROS deficiency.

Sharon O'Neill, Julie Brault, Marie-Jose Stasia, Ulla G Knaus

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Redox biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02926963 (Generation of Powerful Biological Tools - Fibroblast or Inducible Pluripotent Bone Marrow Cells - for Understanding the Pathophysiology of Chronic Granulomatous Disease.), which is not on this map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02926963 naterminatednot on this map

Generation of Powerful Biological Tools - Fibroblast or Inducible Pluripotent Bone Marrow Cells - for Understanding the Pathophysiology of Chronic Granulomatous Disease.

TypeinterventionalSponsorUniversity Hospital, GrenobleRan2010 to 2017Enrolled3ConditionsChronic Granulomatous DiseaseArmssamples collection : hair and skin biopsy
3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 152 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Involvement of ROS signal in aging and regulation of brain functions.The journal of physiological sciences : JPS · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Sharon O'NeillConway Institute, University College Dublin, Dublin, Ireland.
Julie BraultUniversité Grenoble Alpes, TIMC-IMAG Pôle Biologie, CHU de Grenoble, Grenoble, France; CGD Diagnosis and Research Centre, Pôle Biologie, CHU de Grenoble, Grenoble, France.
Marie-Jose StasiaUniversité Grenoble Alpes, TIMC-IMAG Pôle Biologie, CHU de Grenoble, Grenoble, France; CGD Diagnosis and Research Centre, Pôle Biologie, CHU de Grenoble, Grenoble, France.
Ulla G KnausConway Institute, University College Dublin, Dublin, Ireland. Electronic address: ulla.knaus@ucd.ie.
University College Dublin · IECentre Hospitalier Universitaire de Grenoble · FRTranslational Innovation in Medicine and Complexity · FR

Funding

PRIMARY IMMUNODEFICIENCY DISEASE REGISTRY-266030070-266030070N01AI030070 · NIAID · PIRC, INC. · 2003 to 2005
–
NIAID NIH HHS N01 AI030070
6 · The paper itself

Abstract

Maintaining the redox balance between generation and elimination of reactive oxygen species (ROS) is critical for health. Disturbances such as continuously elevated ROS levels will result in oxidative stress and development of disease, but likewise, insufficient ROS production will be detrimental to health. Reduced or even complete loss of ROS generation originates mainly from inactivating variants in genes encoding for NADPH oxidase complexes. In particular, deficiency in phagocyte Nox2 oxidase function due to genetic variants (CYBB, CYBA, NCF1, NCF2, NCF4) has been recognized as a direct cause of chronic granulomatous disease (CGD), an inherited immune disorder. More recently, additional diseases have been linked to functionally altered variants in genes encoding for other NADPH oxidases, such as for DUOX2/DUOXA2 in congenital hypothyroidism, or for the Nox2 complex, NOX1 and DUOX2 as risk factors for inflammatory bowel disease. A comprehensive overview of novel developments in terms of Nox/Duox-deficiency disorders is presented, combined with insights gained from structure-function studies that will aid in predicting functional defects of clinical variants.

Indexed as

Cardiovascular DiseasesDiabetes MellitusDual OxidasesGene ExpressionGranulomatous Disease, ChronicHumansHypothyroidismInflammatory Bowel DiseasesMembrane GlycoproteinsMembrane ProteinsMutationNADPH Oxidase 1NADPH Oxidase 2NADPH OxidasesOxidation-ReductionReactive Oxygen SpeciesCYBB protein, humanDual OxidasesDUOX2 protein, humanDUOXA2 protein, humanMembrane GlycoproteinsMembrane ProteinsNADPH Oxidase 1NADPH Oxidase 2NADPH OxidasesNOX1 protein, humanReactive Oxygen SpeciesChronic granulomatous diseaseDUOXGenetic diseaseHypothyroidismInflammatory bowel diseaseNADPH oxidaseNOXReactive oxygen species (ROS)

Identifiers

PMID26210446
PMCPMC4550764
OpenAlexW1600180689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.